Human immunodeficiency virus type 1 long-term non-progressors: the viral, genetic and immunological basis for disease non-progression.
about
Comparative expression profile of miRNA and mRNA in primary peripheral blood mononuclear cells infected with human immunodeficiency virus (HIV-1)New Insights about Treg and Th17 Cells in HIV Infection and Disease ProgressionDevelopments in HIV-1 immunotherapy and therapeutic vaccination.Human immunodeficiency virus vaccine trialsR77Q and Q3R HIV1-VPR mutations in an otherwise asymptomatic 5-year-old child with repeated ear infectionsPediatric HIV Long-Term Nonprogressors.Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine.Phages and HIV-1: from display to interplay.The natural history of HIV infection.Autophagy plays an important role in the containment of HIV-1 in nonprogressor-infected patients.Bridging HIV-1 cellular latency and clinical long-term non-progressor: an interactomic viewThe number of CCR5 expressing CD4+ T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study.Impact of genetic heterogeneity in polymerase of hepatitis B virus on dynamics of viral load and hepatitis B progression.KIR3DS1/L1 and HLA-Bw4-80I are associated with HIV disease progression among HIV typical progressors and long-term nonprogressors.Positioning of APOBEC3G/F mutational hotspots in the human immunodeficiency virus genome favors reduced recognition by CD8+ T cellsPharmGKB summary: very important pharmacogene information for human leukocyte antigen B.Clinical outcome of HIV viraemic controllers and noncontrollers with normal CD4 counts is exclusively determined by antigen-specific CD8+ T-cell-mediated HIV suppressionAnti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllersSerum protein electrophoresis under effective control of HIV-1 disease progression.Comparison of HIV-1 nef and gag Variations and Host HLA Characteristics as Determinants of Disease Progression among HIV-1 Vertically Infected Kenyan Children.Differences in intermittent and continuous fecal shedding patterns between natural and experimental Mycobacterium avium subspecies paratuberculosis infections in cattle.HIV type 1 mutational patterns in HIV type 1 subtype C-infected long-term survivors in Karonga District Malawi: further analysis and correction.Thirty Years with HIV Infection-Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors.Rapid and Slow Progressors Show Increased IL-6 and IL-10 Levels in the Pre-AIDS Stage of HIV Infection.Mycobacterium tuberculosis infection interferes with HIV vaccination in micePegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integrationDistribution of CCR-5Δ32, CCR2-64I, and SDF-1-3'A alleles among Jordanians.The Immune Fulcrum: Regulatory T Cells Tip the Balance Between Pro- and Anti-inflammatory Outcomes upon InfectionCopy Number Variation within Human β-Defensin Gene Cluster Influences Progression to AIDS in the Multicenter AIDS Cohort Study.Positive selection of mC46-expressing CD4+ T cells and maintenance of virus specific immunity in a primate AIDS model.Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulationElevated hypermutation levels in HIV-1 natural viral suppressors.Preservation of tetherin and CD4 counter-activities in circulating Vpu alleles despite extensive sequence variation within HIV-1 infected individuals.Enhanced FCGR2A and FCGR3A signaling by HIV viremic controller IgG.Is cure of HIV infection in sight?HIV/AIDS: 30 years of progress and future challenges.Dendrimers--revolutionary drugs for infectious diseases.Long-Term Non-Progression and Broad HIV-1-Specific Proliferative T-Cell Responses.DDX1 is an RNA-dependent ATPase involved in HIV-1 Rev function and virus replication.Justification for the inclusion of Gag in HIV vaccine candidates.
P2860
Q21560946-83A869BE-A8F2-4846-BC3D-704C8328140CQ26777036-140B2822-6345-4E53-98B1-68FE16B482FCQ30364312-F9CB6D86-57DB-4E62-B2A9-98CA586BC0BBQ30424366-89375D79-937E-4787-98C7-8C165F93DACEQ33635218-9C12656D-C057-4AB7-BA6C-79C30B3579CCQ34162034-90132FF4-0996-48F4-884C-BBC634E2EE44Q34225659-461D9F30-FFDC-4AFE-A903-291AD9E152F4Q34273397-9D81D204-E83A-4399-A4FC-7FE77180BCC9Q34337675-D79671F8-870B-4521-AC72-A3AA78F682DBQ34373059-6BC95D77-11D1-4037-BEAD-C849561E2225Q34602260-AE96CA39-D2BD-4C86-96F2-383C539C9342Q34740235-F4AF1287-798F-48B1-BDEE-7D83BBD468CEQ34922094-73D65664-D389-4243-A896-E3DAE6671043Q34995326-9EA27FA8-8BD5-48D3-82B9-542F3D461E36Q35145382-7C18C245-74F1-4040-B02A-70AE54DBECB4Q35168561-7BCC900E-849A-4334-8C11-A5A307631913Q35170658-1A0AC0E7-A1DA-4C54-B4F7-7813A24D1C93Q35489088-C875AFE0-595E-44C8-B39F-66F0C4C39CF1Q35728932-18DE7C40-C50C-4435-9DEF-281DE9613ECCQ35758499-4E4964FC-8739-4C7E-8504-3CD0F40DDB76Q35761191-A1EF2140-C44E-486A-AE9E-C2CC9754E6E9Q35799135-17758D1C-7B8C-404B-8B2E-02AC3598AACFQ36010933-B9370FE2-70FC-48DB-9097-7ABE8AB00CA9Q36026644-19E81465-BD1A-47DD-B38D-72D6AF6B1F76Q36121878-9D33442E-00BD-485D-B012-6336BAFCBEB4Q36495526-BC9D6437-F3D2-458B-9DBC-E8EE41A6DE9EQ36509565-84731F52-7AFE-43D2-854E-C2ABFBEB775AQ36625426-E09B9602-FF3C-40E7-9486-55859EEF1666Q36723354-BF73E88A-28A4-4EF8-8202-673FB4AC2E54Q37006885-99DE14FB-5B82-4D4F-843D-AFF45BF4CE50Q37031810-16CF4BFB-7730-4770-A536-DC5BB9384582Q37145307-B23B2A29-0D71-461D-9BA8-30F20D89F708Q37510562-81992F4F-FF22-48E2-BE0C-2F2C2ADB10B1Q37646897-EDEE84DB-1C89-4A3A-8314-D07D2C1CAD39Q37690804-4D39BFE6-8B92-46DF-9BE3-970242DDF15AQ37962420-2ED9F16A-7B08-4064-B823-6941438B4053Q38023801-F9831A94-2CF3-42FE-ACAB-93D9FD37843FQ38086432-16F1D750-BE22-46D2-93FF-E86C0F2F3C59Q38330601-7CF757DA-0E96-49F1-8589-1E71EEC34F69Q38662319-FDF837C1-5785-4BA3-80FA-BB891606F11B
P2860
Human immunodeficiency virus type 1 long-term non-progressors: the viral, genetic and immunological basis for disease non-progression.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Human immunodeficiency virus t ...... s for disease non-progression.
@ast
Human immunodeficiency virus t ...... s for disease non-progression.
@en
type
label
Human immunodeficiency virus t ...... s for disease non-progression.
@ast
Human immunodeficiency virus t ...... s for disease non-progression.
@en
prefLabel
Human immunodeficiency virus t ...... s for disease non-progression.
@ast
Human immunodeficiency virus t ...... s for disease non-progression.
@en
P356
P1476
Human immunodeficiency virus t ...... s for disease non-progression.
@en
P2093
David J Sullivan
Kate Poropatich
P304
P356
10.1099/VIR.0.027102-0
P407
P577
2010-11-24T00:00:00Z